A meal may leave you satisfied for longer with Tirzepatide. The drug uses meal hormones GIP and GLP-1 to affect hunger and sugar.
Your doctor considers more than how much you eat. Treatment choices also depend on your illnesses, other medicines and possible side effects.
A weekly shot can ease hunger while lowering raised sugar
You may feel satisfied sooner while your sugar readings improve. Tirzepatide uses the actions of meal hormones called GIP and GLP-1.
Earlier medicines used the meal hormone GLP-1's action alone. Tirzepatide brought larger weight and sugar improvements in treatment comparisons.
Those larger averages don't predict your own results. Your doctor also considers whether side effects could trouble you.
Prescribed weekly shots put the drug under your skin. About half the medicine remains after 5 days.
Approval covers obesity, type 2 diabetes and sleep apnea. Sleep apnea is breathing that repeatedly stops while you're asleep.
Approval doesn't include type 1 diabetes. Your health history can mean you can't use the drug.
Scientists changed one drug to use both hormone actions. The shot isn't two natural hormones mixed together.
Tirzepatide had another name during early testing
You might come across LY3298176 in an early paper. That's the drug now known as tirzepatide, not a different treatment.
The different name doesn't mean the drug itself changed. A person's nickname and full name can likewise mean one person.
GIP and GLP-1 are meal hormones, rather than earlier drug names [7]. Scientists used GIP as the starting design for tirzepatide.
They changed that design to add the meal hormone GLP-1's action [1]. Tirzepatide uses both actions in one manufactured drug.
The medicine isn't natural GLP-1 put into a shot. The medicine also received a small added fat part.
That added part lets a blood protein carry the drug. Slower removal leaves about half the medicine after 5 days.
Tirzepatide acts by attaching at the meal hormone GLP-1's usual places. The drug also attaches at the other meal hormone's places.
The attachment places are proteins on cells, often called receptors. Unlike natural GLP-1, the drug's added fat slows its clearing.
The Tirzepatide peptide (a protein chain) is made to last
Tirzepatide joins 39 amino acids, parts joined to form a protein. This short manufactured chain is a peptide.
The starting design used GIP, a hormone your gut releases during meals. Scientists changed the medicine to use the meal hormone GLP-1's action too [1].
Hormones attach at proteins on the outside of cells. Tirzepatide uses those same attachment places to produce both actions.
At position 20 in the chain, scientists added a fat part. That fat part belongs to the medicine, not your own body fat.
The added fat lets albumin, a blood protein, carry the medicine. Albumin attaches to the drug and lets go again.
Your body clears the attached drug more slowly [1]. Roughly half remains after 5 days, supporting weekly treatment.
Your body doesn't naturally make this changed chain. Scientists manufacture tirzepatide for use as medicine.
Swallowing the drug would allow your gut to digest the chain. Prescribed treatment therefore uses a shot beneath your skin.
The long stay doesn't guarantee any particular weight loss. Your results also depend on your health and response.
Approved uses cover sugar, weight and breathing pauses with obesity
Breathing pauses can disturb sleep even when you don't notice them. As of June 2026, tirzepatide has three approved uses [7][15][33].
Use 1 helps adults manage type 2 diabetes with exercise and diet. May 2022 brought approval for this type 2 diabetes use.
Use 2 is ongoing weight treatment with diet and activity. November 2023 brought approval for the weight use.
Eligibility depends on weight in relation to height. A score reaching 30 puts your weight in the obesity range.
A score of 27 qualifies if you have a related illness. Your doctor can explain your score using your own measurements.
Use 3 covers more severe sleep apnea with obesity. Sleep apnea repeatedly stops your breathing while you sleep.
This approval came in 2024 after studies counted breathing pauses. SURMOUNT-OSA found 25.3-29.3 fewer pauses per hour with tirzepatide [34].
Placebo (shots without medicine) brought about 5 fewer pauses per hour. These figures are falls from the earlier counts, not pauses remaining.
Approval doesn't cover type 1 diabetes or weight care outside those limits. The sleep-apnea use also requires obesity.
Certain thyroid cancers in you or relatives prevent use [15]. Mice and rats developed thyroid tumors when tested with related medicines.
Researchers haven't shown that people face the same tumor risk as those animals. Your treatment choice can't ignore that label warning.
Multiple Endocrine Neoplasia syndrome type 2 is an inherited illness that also prevents use. Several glands can develop tumors with that illness.
Tirzepatide adds a meal-hormone action beyond earlier drugs
Earlier medicines use GLP-1, a meal hormone helping your pancreas release insulin [9]. That action also eases hunger and slows stomach emptying.
Tirzepatide combines GLP-1's action with GIP, another meal hormone [10]. The drug isn't a mixture of the natural hormones.
GIP affects insulin release and helps fat tissue respond to insulin. Scientists tested tirzepatide in obese mice lacking GLP-1's working attachment proteins.
The mice still used insulin more effectively during treatment [10]. That benefit didn't depend on losing weight.
Those mice can't establish a separate benefit for your fat tissue. People in direct treatment comparisons give your doctor stronger evidence.
SURPASS-2 followed 1879 adults with type 2 diabetes for 40 weeks [3]. Weight and sugar improved further with tirzepatide than semaglutide at 1 mg.
Semaglutide is another medicine treating diabetes and excess weight. Its different action doesn't make either drug the right choice for everyone.
SURMOUNT-5 followed 751 adults with obesity over 72 weeks [5]. People lost 20.2% of starting weight with tirzepatide, compared with 13.7% with semaglutide.
Your own loss could differ, and comfort during treatment matters. Your doctor weighs both benefit and harm when considering your prescription.
Tirzepatide mechanism of action explains the way the medicine works. You can read more about the hormone actions and the cell tests.